Seeing the Potential in mHealth

As mHealth continues to grow and apps expand into different areas, the opportunities for health improvements also grow, as do complexities.  This article ─ including comments from ERT’s Dr. Chris Watson and Gavin Birchnall ─ reviews how pharmaceutical companies will need to carefully balance mHealth innovation with a clear understanding of the evolving regulatory guidelines.

Click here to read the full article.

Share